cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

Rhea-AI Summary

cbdMD (NYSE American: YCBD) has announced it will host a conference call on Thursday, February 13, 2025, at 4:20 p.m. Eastern Time to discuss the company's financial results for the first quarter of fiscal year 2025, ended December 31, 2024, and business progress.

The conference call will be accessible via multiple channels, including USA/Canada toll-free number (844-763-8274) and International number (647-484-8814). A replay will be available through USA/Canada (855-669-9658) and International (412-317-0088) numbers using passcode 7970691. Additionally, a webcast replay will be accessible through March 13, 2026.

Charlotte, North Carolina--(Newsfile Corp. - February 7, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, February 13, 2025, to discuss the company's December 31, 2024 first quarter of fiscal year 2025 financial results and business progress.

CONFERENCE CALL DETAILS

Thursday, February 13, 2025, 4:20 p.m. Eastern Time
USA/Canada:	844-763-8274
International:	647-484-8814
Teleconference Replay dial in:
USA/Canada:	855-669-9658
International:	412-317-0088
Replay Passcode:	7970691
Webcast/Webcast Replay link - available through March 13, 2026:
https://www.gowebcasting.com/13965

 

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free¹ CBD products, including NSF Certified for Sport® products, as well as our new Full Spectrum products. Our cbdMD brand currently includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including our Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our ATRx brand of natural functional mushroom support. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free¹ CBD oil and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, or ATRxlabs.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.¹ THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240114

FAQ

When will YCBD report its Q1 FY2025 earnings?

cbdMD (YCBD) will report its Q1 FY2025 earnings on Thursday, February 13, 2025, at 4:20 p.m. Eastern Time.

How can investors access YCBD's Q1 2025 earnings call?

Investors can access the call through USA/Canada (844-763-8274) or International (647-484-8814) numbers, or via webcast at www.gowebcasting.com/13965.

How long will YCBD's Q1 2025 earnings call replay be available?

The webcast replay will be available through March 13, 2026, and can be accessed via telephone using replay passcode 7970691.

What period does YCBD's upcoming earnings report cover?

The earnings report covers the first quarter of fiscal year 2025, which ended on December 31, 2024.